Chief Scientific Officer
Xavier Leroy is Chief Scientific Officer at Domain Therapeutics. He joined the company in 2019 as Chief Technical Officer to supervise the development of Domain proprietary technologies. As CSO, Xavier defines the orientation, impulse strategic decisions and guide pipeline expansion. He has more than 20 years of expertise of GPCR pharmacology and discovery/translational research bringing successfully numerous programs from research to the regulatory development. Prior to joining Domain Therapeutics, he was head of drug discovery at iTeos, Belgium, a clinical stage IO company. Xavier started his career at Axovan before joining Actelion Pharmaceuticals Ltd, Switzerland, in positions of increasing seniority to develop multiple GPCR-targeting programs in the field of neuroscience and inflammation. Xavier completed a post-doctoral fellowship at Novartis, Switzerland. He has PhD in molecular and cellular biology from the University of Bretagne Occidentale, France.